<img height="1" width="1" src="https://www.facebook.com/tr?id=688963825162967&amp;ev=PageView &amp;noscript=1">

Preventative Care Assessment to take control of your colorectal health

GeneType for Colorectal cancer is the most accurate, cutting-edge clinical risk assessment available. Analyzing the most meaningful and important polygenic and clinical risk factors to predict your chance of developing colorectal cancer. Risk assessment is a staple in preventative care; if you are at high risk, there are more colorectal cancer screening and prevention options for you.

GeneType for Colorectal cancer is a clinical test, ordered by a physician, and designed to identify risk early, so you can better understand what can be done to prevent the disease or to detect it earlier.

Order Now

How it works?

Purchase your test kit

Purchase your test kit

Arrow
Swab cheek and send to laboratory

Swab cheek and send to laboratory

Arrow
Discuss results as part of a personalized screening plan

Discuss results as part of a personalized screening plan

Order Now

Accurate And Secure results
based on sound science.

  • GeneType for Colorectal cancer is a novel DNA-based risk assessment based on a proprietary algorithm designed.
  • Validated and performed by a state-of-the-art, NATA-accredited and CLIA certified lab
  • GeneType for Colorectal cancer is only clinically proven in Caucasian populations.
Order Now

What does it tell you?

Risk

Average Risk

You have the same risk as other individuals of your sex, age and ethnicity. Follow your healthcare provider's instructions on colorectal screening.

Increased Risk

Your colorectal health discussion with your healthcare provider should cover a range of strategies to reduce your risk including screening methods and frequency, medications and lifestyle factors.

Hey. Have questions? We have answers.

Find our most frequently asked questions bellow. In case you don't find an answers to your question contact us directly.

Will insurance cover this test?

This test is not generally covered by insurance. Your ordering healthcare provider will discuss the cost of the test with you. A credit card authorization form will be included in the test kit that list the payment options.

What will my GeneType for Colorectal Cancer results tell me?

Your results will tell you, based on genetics and other risk factors, your risk for developing sporadic colorectal cancer over three different time periods: the next five years, the next ten years, and in your lifetime. Your risk will be compared to the average risk for someone of your age, ethnicity, and sex. You and your healthcare provider can use this information to develop a personalized screening and risk reduction plan.

How does GeneType for Colorectal Cancer assess my risk?

Your results will tell you, based on genetics and other risk factors, your risk for developing sporadic colorectal cancer over three different time periods: the next five years, the next ten years, and in your lifetime. Your risk will be compared to the average risk for someone of your age, ethnicity, and sex. You and your healthcare provider can use this information to develop a personalized screening and risk reduction plan.

Why is GeneType for Colorectal Cancer only available for individualsbetween the ages of 30-80?

The majority (about 90%) of colorectal cancer diagnoses occur in individuals over 50. Our test examines risk in individuals before they are eligible for routine screening and up until the age when screening is no longer recommended.

Which ethnicities is GeneType for Colorectal Cancer available to?

At this time, GeneType for Colorectal Cancer is only validated for assessing colorectal cancer risk in individuals of Caucasian ancestry. We are continuing to improve our test and add validated models for additional ethnicities.

Is GeneType for Colorectal Cancer a blood test?

No. GeneType for Colorectal Cancer is a DNA test from a cheek swab. Your healthcare provider will rub the swab between your cheek and gums to collect the sample.

See More

Our Partners

Group 20